Protein quality control collapse may explain why cancer immunotherapy fails

Scientists from The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) report key findings about the underlying mechanisms of immune system stress response to protein misfolding, launching a new approach to cancer immunotherapy treatment targeting the protein production cycle.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup